Calibration and evaluation of routine methods by serum certified reference material for aldosterone measurement in blood-Reference-Cited by-同舟云学术

Calibration and evaluation of routine methods by serum certified reference material for aldosterone measurement in blood

Published:2016 Issue:12 Volume:63 Page:1065-1080
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Nishikawa Tetsuo¹,Omura Masao¹,Kawaguchi Migaku²,Takatsu Akiko²,Satoh Fumitoshi³,Ito Sadayoshi⁴,Kurihara Isao⁵,Itoh Hiroshi⁵,Yanase Toshihiko⁶,Shibata Hirotaka⁷,Oki Yutaka⁸,Naruse Mitsuhide⁹,Sakurai Keiko¹⁰,Sasamoto Hidehiko¹¹,Kuwa Katsuhiko²

Affiliation:

1. Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Yokohama, Japan

2. National Metrology Institute of Japan, National Institute of Advanced Industrial Science and Technology, Tsukuba, Japan

3. Division of Clinical Hypertension, Endocrinology & Metabolism, Tohoku University Graduate School of Medicine, Sendai, Japan

4. Division of Nephrology, Endocrinology and Vascular Medicine, Department of Medicine, Tohoku University School of Medicine, Sendai, Japan

5. Department of Endocrinology, Metabolism and Nephrology, School of Medicine Keio University, Tokyo, Japan

6. Department of Endocrinology and Diabetes Mellitus, School of Medicine, Fukuoka University, Fukuoka, Japan

7. Department of Endocrinology and Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Yufu, Japan

8. Department of Community and Family Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan

9. Department of Endocrinology, Metabolism and Hypertension, National Hospital Organization Kyoto Medical Center, Kyoto, Japan

10. Reference Material Institute for Clinical Chemistry Standards, Kawasaki, Japan

11. Aska Pharma Medical Co., Ltd., Kawasaki, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/63/12/63_EJ16-0304/_pdf

Reference10 articles.

1. 1. Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, et al. (2009) Guidelines for the diagnosis and treatment of primary aldosteronism. Folia Endocrinol Japonica 86 Supplement-2: 1-19 (In Japanese).

2. 2. Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, et al. (2011) Guidelines for the diagnosis and treatment of primary aldosteronism — The Japan Endocrine Society 2009. Endocr J 58: 711-721.

3. 3. Omura M, Makita K, Matsui A, Nishikawa T (2012) Diagnosis and criteria. In Ito S and Nishikawa T (ed) Point of hypertension care, know-how and evaluation of adrenal venous sampling (AVS) for primary aldosteronism diagnosis. Medical Review, Tokyo: 11-19 (In Japanese).

4. 4. ISO17511 (2003) : In vitro diagnostic medical devices — Measurement of quantities in biological samples — Metrological traceability of values assigned to calibrators and control materials.

5. 5. CLSI C37-A (1999) : Preparation and validation of commutable frozen human serum pools an secondary reference materials for cholesterol measurement procedures; Approved Guideline. Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, USA.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of unilateral hyperaldosteronism in primary aldosteronism: impact of a novel chemiluminescent immunoassay for measuring plasma aldosterone in Japan;Hypertension Research;2024-07-29

2. Association Between Plasma Aldosterone Concentration and Intraglomerular Hemodynamics in Primary Aldosteronism;American Journal of Hypertension;2024-05-22

3. Adrenal venous sampling criteria for chemiluminescent enzyme immunoassay as a preferable alternative to radioimmunoassay in primary aldosteronism;Endocrine Journal;2024

4. Impact of the transition from radioimmunoassay (RIA) to chemiluminescent enzyme immunoassay (CLEIA) for the measurement of plasma aldosterone concentration (PAC) on the diagnosis of primary aldosteronism (PA) <i>via</i> retrospective analyses in Okinawa, Japan;Endocrine Journal;2024

5. A Case of 17α-hydroxylase/17,20-lyase Deficiency Diagnosed at 45 Years of Age with Hyperaldosteronism;Internal Medicine;2024